| 中文别名： |
乌苯美司;N-[(2S,3R)-3-氨基-2-羟基-4-苯丁酰]-L-亮氨酸;贝他定;贝他定(苯丁抑制素);乌苯美司(乌苯美司);乌苯美司-D5(乌苯美司-D5);乌苯美司-D7(乌苯美司-D7);乌苯美司对照品;乌苯美司及其中间体;抑氨肽酶;抑氨肽酶,乌苯美司,贝他定;([2S,3R]-3-氨基-2-羟基-4-苯基丁酰基)-L-亮氨酸;[S-(R*,S*)]-N-(3-氨基-2-羟基-1-氧代-4-苯丁基)-L-亮氨酸;N -[（2S,3R）-3 -氨基- 2-羟基- 4-苯基丁酰] -L 亮氨酸;N-[(2S,3R)-3-氨基-2-羟基-4-苯基丁酰基]-L-亮氨酸;乌苯美司,N-[(2S,3R)-3-氨基-2-羟基-4-苯基丁酰基]-L-亮氨酸 |
| 英文别名： |
ubenimex;(S)-2-((2S,3R)-3-Amino-2-hydroxy-4-phenylbutanamido)-4-methylpentanoic acid;[(2S,3R)-3-Amino-2-hydroxy-4-phenylbutyryl]-L-leucine;[(2S003R)-3-Amino-2-hydroxy-4-phenylbutyryl]-L-leucine;BESTATIN;N-((2S,3R)-3-AMINO-2-HYDROXY-4-PHENYLBUTYRYL)-L-LEUCINE;N-[(2S,3R)-3-Amino-2-hydroxy-4-phenylbutyryl]-L-leucine;BENIMEX;Bestatin,UbeniMex;nk421;[S-(R*,S*)]-N-(3-Amino-2-hydroxy-1-oxo-4-phenylbuty1)-L-leucine;Direnavir;Bestatin;Ubenimex;Ubenimexum [Latin];Ubenimex (Bestatin);Ubenimex [INN:JAN];Ubenimex(Bestatin);NK 421;I0J33N5627;3-(R)-Amino-2-(S)-hydroxy-4-phenylbutanoyl-(S)-leucine;[(2s,3r)-3-amino-2-hydroxy-4-phenylbutanoyl]-l-leucine;N-[(2S,3R)-3-Amino-2-hydroxy-4;Ubenimex;Bestatin;UBENIMEX [MI];NCGC00025323-01;KBio2_000273;CCG-101071;N-((2S,3R)-3-AMINO-2-HYDROXY-4-PHENYLBUTANOYL)-LEUCINE;NCGC00025323-02;NCGC00025323-03;((2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl)-L-leucine;UBENIMEX [INN];KBioSS_000273;HMS1791N15;NCGC00025323-04;(S)-2-((2S,3R)-3-amino-2-hydroxy-4-phenylbutanamido)-4-methylpentanoicacid;N-[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl]-L-leucine;NC00321;KBio2_005409;HMS3402N15;KBioGR_000273;NK-421;2-(3-AMINO-2-HYDROXY-4-PHENYL-BUTYRYLAMINO)-4-METHYL-PENTANOIC ACID;MFCD00083262;NCGC00025323-14;NSC-779839;CS-1910;Ubenimexum;Ubenimex- Bio-X;KS-5207;BDBM50367209;(2S)-2-[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanamido]-4-methylpentanoic acid;Ubenimex, Bestatin;UBENIMEX [MART.];Lopac0_000214;N-[(2S,3R)-3-Amino-2-hydroxy-4-phenylbutyryl]-L-leucine, 97%;HMS2052A03;SDCCGSBI-0050202.P003;BU164499;(-)-bestatin;MLS006010137;58970-76-6;HMS3676N16;1txr;Z2242062173;(2S)-2-[[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl]amino]-4-methylpentanoic acid;IDI1_034023;BRD-K59574735-001-02-7;NSC-265489;(S-(R*,S*))-N-(3-Amino-2-hydroxy-4-phenylbutyroyl)-L-leucine;U0111;([2S,3R]-3-Amino-2-hydroxy-4-phenylbutanoyl)-L-leucine;W-105351;L-LEUCINE, N-((2S,3R)-3-AMINO-2-HYDROXY-1-OXO-4-PHENYLBUTYL)-;HY-B0134;HMS3268O06;Bio2_000273;Ubenimex,(S);Q10909912;NSC779839;NSC 265489;KBio3_000546;L-Leucine, N-[(2S,3R)-3-amino-2-hydroxy-1-oxo-4-phenylbutyl]-;SCHEMBL7944;Ubenimex, solid;EX-A1292;A832093;N-[(2S,3R)-3-Amino-2-hydroxy-1-oxo-4-phenylbutyl]-L-leucine;BDBM23971;HMS3412N16;58970-76-6 (free base);Ubestatin;CHEMBL29292;HMS1989N15;EINECS 261-529-2;UBENIMEX [JAN];HMS2232H13;NCGC00025323-08;MLS000028649;BCBcMAP01_000178;BCP0726000308;AKOS016339610;UBENIMEX [WHO-DD];KBio3_000545;MLS001424177;(-)-N-((2S,3R)-3-Amino-2-hydroxy-4-phenylbutyryl)-L-leucine;NCGC00025323-06;HMS3715B20;(2S)-2-[[(2S,3R)-3-amino-2-hydroxy-4-phenyl-butanoyl]amino]-4-methyl-pentanoic acid;SMP1_000030;(3-Amino-2-hydroxy-4-phenylbutanoyl)-L-leucine;SR-01000075724-3;BSPBio_001553;AB00698345_05;UNII-I0J33N5627;NCGC00025323-05;s1591;BRD-K59574735-001-05-0;HMS1361N15;(S)-2-((2S,3R)-3-amino-2-hydroxy-4-phenylbutanamido)-4-methylpentanoic acid;SMR000059165;VGGGPCQERPFHOB-RDBSUJKOSA-N;EN300-738859... |
沪公网安备 
